Monitoring HIV drug resistance using early warning indicators in China: Results from a pilot survey conducted in 2008

Clinical Infectious Diseases

Volumn 54, Issue SUPPL. 4, 2012, Pages

  Ma, Ye ^a   Zhang, Fujie ^a,b   Li, Huiqin ^c   Wu, Hao ^d   Zhang, Jianbo ^e   Ding, Yusheng ^f   Zhao, Decai ^a   Fang, Hua ^a   Zhou, Shuntai ^a   Liu, Zhongfu ^a   Zhang, Lan ^g   Osborne, Connie ^g   Seguy, Nicole ^g   Zhao, Yan ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Yunnan AIDS Care Center   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

^e Dali Second People's Hospital   (China)

^f Ruili Minzu Hospital   (China)

^g WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE;

ADOLESCENT; ADULT; CHINA; CLINICAL ASSESSMENT; DRUG RETENTION; FOLLOW UP; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PATIENT MONITORING; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-RETROVIRAL AGENTS; CHINA; COHORT STUDIES; DELIVERY OF HEALTH CARE; DRUG RESISTANCE, VIRAL; HEALTH STATUS INDICATORS; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MEDICATION ADHERENCE; PILOT PROJECTS; POPULATION SURVEILLANCE; WORLD HEALTH ORGANIZATION;

EID: 84860372123     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir1018     Document Type: Review

References (8)

1. Bennett DE, Bertagnolio S, Sutherland D, et al. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir Ther 2008; 13(suppl 2):1-13. (Pubitemid 352019085)
2. Ma Y, Zhang F, Zhao Y, et al. Ministry of Health, China 2010 UNGASS Country Progress Report (2008-2009). 2010; 39:973-9.
3. Zhang F, Haberer JE, Wang Y, et al. eds. National free HIV antiretroviral treatment handbook. 2nd ed. Beijing, China: People's Medical Publishing House, 2008.
4. Zhang F, Haberer JE, Wang Y, et al. The Chinese free antiretroviral treatment program: challenges and responses. AIDS 2007; 21(suppl 8):S143-8.
5. Ma Y, Zhang F, Zhao Y, et al. Cohort profiles: the Chinese national free antiretraoviral treatment cohort. Int J Epidemiol 2010; 39:973-9.
6. Zhang F, Dou Z, Ma Y, et al. Five-year outcomes of the China national free antiretroviral treatment program. Ann Intern Med 2009; 151: 241-51.
7. Ma Y, Zhao D, Yu L, et al. Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China. Clin Infect Dis 2010; 50:264-71.
8. Sethi AK, Celantano DD, Gange SJ, et al. Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance. Clin Infect Dis 2003; 37:1112-18. (Pubitemid 37323668)